Rovi will continue to have a capital role in the manufacture of vaccines against the coronavirus. The company will produce Moderna’s omicron-adapted vaccine in Granada. This was confirmed to this medium by company sources, who explained that they have everything ready to undertake this new task for the new vaccination campaign.
The relationship between the Madrid-based pharmaceutical company and the American biotech company began in mid-2020, when they signed their first agreement to fill and package the first versions of the coronavirus vaccine. Subsequently, Rovi fine-tuned its facilities in Granada and agreed with Moderna to carry out the necessary technology transfer to be the first company in Spain capable of developing sera using the messenger RNA technique.
The harmony between both companies is total. They have a collaboration agreement in different therapeutic fields for the next ten years. In addition, the American company will invest 500 million euros this year for the production of vaccines and medicines. Rovi will be the destination for much of those investments.
Rovi’s facilities, both in Granada and Madrid, are prepared to supply third-party companies with the material they need. The third-party manufacturing business is precisely the engine that has allowed the company to reach the Ibex, along with its historic heparin business. In addition, its innovative platform is beginning to give results, with a drug against schizophrenia as the first exponent, already available in Spain.
Moderna’s adapted vaccine is one of the two chosen to date by Europe and Spain to start the new autumn vaccination campaign. The biotech company paused its previous shipments at the request of member states, aware that the American firm was finalizing its adapted serum. Now, the supply has been resumed and, like a year ago, a Spanish company will be one of the great architects of production.
On the other hand, Rovi is immersed in obtaining the commercialization of its drug against schizophrenia in the United States. The FDA technicians suspended their visit to the pharmaceutical facilities and it is at the expense of being able to make a new appointment.
Facebook Comments
Disqus